CHU EYE INSTITUTE

What CHU EYE INSTITUTE does

Chu Eye Institute is a family-owned ophthalmology practice headquartered in Fort Worth, Texas, operating across four DFW-area locations including the main cultural-district clinic, FW Specialty Surgicare, Medical City Surgery Center Fort Worth, and a Southlake satellite. Founded in 2012 and led by fellowship-trained cornea surgeon Dr. Richard Chu, the practice delivers a full spectrum of eye care spanning routine exams, chronic disease management (glaucoma, diabetic retinopathy, macular degeneration), and advanced surgical services including cataract surgery with premium IOL options (PanOptix, Toric), LASIK/PRK/EVO ICL, cornea transplants (DSEK/DMEK), keratoconus treatments (corneal crosslinking, Intacs, PTK), and minimally invasive glaucoma surgery.

The underlying technology stack is conventional but advanced for a community practice, comprising OCT imaging, corneal topography, pachymetry, wavefront-optimized LASIK platforms, and biologic treatments such as CAM360 AmnioGraft. No proprietary technology, patents, AI systems, or software products are indicated; practice operations rely on third-party tools including Maxineyes for scheduling, LeadingReach for referral management, and CareCredit for patient financing.

The revenue model is professional services with three primary streams: surgical procedures (mix of insurance-reimbursed cataract surgery and self-pay elective LASIK/refractive), ongoing medical and vision exams with disease management, and out-of-pocket premium lens upgrades. Pricing is quote-based with insurance coverage varying by procedure (cataract surgery with monofocal lenses typically Medicare-covered; LASIK/PRK elective). Go-to-market is sales-led via direct patient scheduling, an active optometrist/primary-care referral network, and participating-provider status with major insurance plans including Medicare, VSP, United Healthcare, Aetna, Cigna, and Blue Cross Blue Shield.

Name

CHU EYE INSTITUTE

Legal name

Chu Eye Institute

Website

https://chueye.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Chu Eye Institute is a family-owned ophthalmology practice in Fort Worth, Texas, offering cataract surgery, LASIK, cornea transplants, glaucoma treatment, and chronic eye disease management to DFW-area seniors, refractive-correction patients, and referring optometrists' patients.

Ownership category

akta.pro rank

Product category

Ophthalmology Services

NAICS

Offices of Optometrists (62132)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Ophthalmology Clinics (Medical & Surgical Eye Care) (HLAKAKAC)

akta.pro secondary industries

Cornea, External Disease & Refractive Surgery (LASIK/PRK) (HLAKAKAF), Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH), Retina & Vitreous Specialists (HLAKAKAE)

Keywords

• Ophthalmology services
• Cataract surgery
• LASIK vision correction
• Cornea transplants
• Eye disease management

Headquarters

HQ city

Fort Worth

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Surgical Procedures: Revenue from surgical procedures including cataract surgery, LASIK, cornea transplants, and glaucoma treatments. Includes both medically necessary procedures (often insurance-covered) and elective procedures.
2. Medical and Vision Exams: Revenue from eye exams, diagnostics, and ongoing disease management for conditions like glaucoma, diabetic retinopathy, and macular degeneration.
3. Premium Lens Upgrades: Additional revenue from premium lens upgrades (PanOptix, Toric IOLs) during cataract surgery that are not covered by standard insurance.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Chu Eye Institute is a family-owned ophthalmology practice delivering surgical and medical eye care, including cataract surgery with premium IOL options (PanOptix, Toric), wavefront-optimized LASIK/PRK and EVO ICL refractive correction, partial-thickness cornea transplants (DSEK/DMEK), glaucoma laser and MIGS procedures, corneal crosslinking and keratoconus management, dry eye treatments including CAM360 AmnioGraft, and ongoing management of diabetic retinopathy, macular degeneration, and ocular hypertension. Care is delivered across Fort Worth clinic locations and affiliated outpatient surgery centers, supported by OCT imaging, corneal topography, and pachymetry diagnostics.

Product overview

Chu Eye Institute is a family-owned ophthalmology practice offering a comprehensive range of eye care services. The practice specializes in surgical procedures including cataract surgery (with PanOptix and Toric IOL premium lens options), LASIK/PRK/EVO ICL vision correction, cornea transplants (DSEK and DMEK), glaucoma surgery (SLT, MIGS), and keratoconus treatments (crosslinking, Intacs, PTK). Medical services include dry eye treatment (CAM360 AmnioGraft), eye disease management for diabetic retinopathy and macular degeneration, and diagnostic imaging including retinal OCT. The practice operates at multiple Fort Worth locations with surgical procedures performed at FW Specialty Surgicare and Medical City Surgery Center Fort Worth.

Differentiator

Problem solved

Functional benefit

Products and services

• Cataract Surgery Surgical removal of clouded natural lenses with replacement by intraocular lenses (IOLs). Offers standard monofocal lenses and premium options including PanOptix Trifocal and Toric IOLs for astigmatism correction. For adults with cataracts.
• LASIK & PRK Laser vision correction procedures including Wavefront-optimized LASIK and PRK for refractive errors such as nearsightedness, farsightedness, and astigmatism. For adults seeking freedom from glasses or contact lenses.
• EVO ICL (Implantable Collamer Lens) Implantable collamer lens procedure for vision correction, suitable for patients who may not be ideal LASIK candidates. For adults seeking refractive correction.
• Cornea Transplants (DSEK & DMEK) Partial-thickness cornea transplant procedures for conditions like Fuchs' dystrophy, bullous keratopathy, and cornea scarring. DSEK and DMEK replace damaged inner corneal layers with smaller incisions, lower rejection risk, and faster recovery.
• Glaucoma Surgery Minimally invasive glaucoma treatments including Selective Laser Trabeculoplasty (SLT), Argon Laser Trabeculoplasty (ALT), Laser Peripheral Iridotomy (LPI), and Minimally Invasive Glaucoma Surgery (MIGS) to reduce intraocular pressure. For patients with glaucoma.
• Dry Eye Treatment Medical management of dry eye syndrome including CAM360 AmnioGraft treatment using preserved amniotic membrane tissue with anti-inflammatory and healing properties, prescription drops and sprays, and personalized treatment plans based on tear film evaluation. For patients with dry eye.
• Keratoconus Solutions Comprehensive keratoconus management including Corneal Crosslinking (CXL) using vitamin B2 drops and UV light to strengthen corneal collagen, Intacs cornea implants, and Phototherapeutic Keratectomy (PTK) to stabilize the cornea and improve vision.
• Eye Disease Management Medical monitoring and management of chronic eye conditions including diabetic retinopathy, macular degeneration, and ocular hypertension using OCT imaging, visual field testing, and retinal imaging.
• Retinal OCT Imaging Optical Coherence Tomography (OCT) for early detection of diabetic macular edema, retinal layer visualization, and monitoring of diabetic eye disease progression.

Quantifiable outcome

• Cataract surgery typically takes less than 15 minutes with outpatient recovery
• +2 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature6 records

Partnerships

One partnership is on record.

• Medical City Surgery Center Fort WorthcoreOthersChu Eye Institute partners with Medical City Surgery Center Fort Worth to deliver expert ophthalmic surgical care in a high-tech, fully accredited outpatient setting. The facility is located near the main clinic and provides a seamless surgical experience for cataract surgery, glaucoma treatment, and specialized corneal procedures.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Regional players

• Heritage Eye Center: DFW-area ophthalmology practice offering cataract and general eye care services. Comparable independent community-ophthalmology positioning in adjacent North Texas submarkets.
• Whitsett Vision Group: Multi-location Texas ophthalmology practice with similar service mix (LASIK, cataract, glaucoma). Comparable scale; serves a different metro (Houston) but similar independent, physician-led model.
• Mann Eye Institute: Large Texas-based ophthalmology and LASIK practice headquartered in Houston. Comparable service breadth; serves different geography but operates similar premium-IOL and refractive business model.

Direct peers

• Kleiman Evangelista Eye Centers: DFW-based multi-specialty ophthalmology and optometry group providing cataract, LASIK, glaucoma, and cornea care. Closely comparable in scale and service breadth.
• Key-Whitman Eye Center: Multi-location DFW ophthalmology practice offering LASIK, cataract surgery, cornea, and glaucoma services. Direct regional competitor overlapping Chu Eye's service mix in North Texas.
• Cornea Associates of Texas: Dallas-based subspecialty practice focused on cornea, refractive, and cataract surgery. Direct overlap with Chu Eye's cornea transplant, keratoconus, and LASIK service line.

Broad incumbents

• TLC Laser Eye Centers: Established national LASIK provider competing for the elective refractive segment of Chu Eye's service line. Larger brand and footprint but narrower surgical focus.
• LasikPlus: National refractive surgery chain with high LASIK volume. Competes for elective vision correction patients in the DFW market; broader geographic reach with less subspecialty depth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/chu-eye-institute

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CHU EYE INSTITUTE